search
Back to results

Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood

Primary Purpose

Premature Birth

Status
Active
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Early Intervention
Sponsored by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Premature Birth focused on measuring Premature Birth, DNA Methylation, L1 Elements, Epigenometics, Early Intervention, Brain Development, Neurodevelopment, Parent-infant interaction, Massage therapy, Visual interaction

Eligibility Criteria

24 Weeks - 32 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Gestational age at birth between 24+0 and 32+6 weeks
  • Mothers age over 18 years
  • Good comprehension of the Italian language
  • Written informed consent signed by both parents

Exclusion Criteria:

  • Infants with major genetic disorders and malformations
  • Parents declined study participation
  • Single-parent family
  • Parents with obvious cognitive or psychiatric disorders and drug addiction

Sites / Locations

  • NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Early Intervention

Arm Description

All the enrolled preterm infants are assigned to receive the early neurodevelopmental intervention during the NICU stay.

Outcomes

Primary Outcome Measures

L1 Promoter Methylation Levels on Biological Materials
Epigenetic analysis is performed on biological materials: cord blood sample and buccal swab at birth, peripheral blood sample and buccal swab at NICU discharge/term equivalent age, buccal swab collected during the follow up assessment at 12 and 24 months of corrected age.

Secondary Outcome Measures

Conventional and advanced brain Magnetic Resonance Imaging (MRI)
Evaluation of brain development and maturation
Neurological Examination
Hammersmith Neonatal Neurological Examination (HNNE)
General Movements Examination
Prechtl's Qualitative Assessment of General Movements
Visual Assessment
Neonatal Visual Assessment Battery developed by Ricci et al. The assessment evaluates the following items: ocular spontaneous motility, ability to fix and follow a target, reaction to colour, visual acuity and visual attention at distance.
Neurodevelopmental Outcome
Children development assessed using the Griffiths Mental Development Scales, performed at 12 and 24 months of corrected age. Mean score is 100. General score has a Standard deviation of 12 and sub scales have a Standard Deviation of 16. Higher scores indicate better outcomes.
Behavioral Outcome
Children behavior assessed using the Child Behavior Checklist (CBCL). It is a parent report form to screen for emotional, behavioral and social problems. Lower scores indicate better outcomes. A T score above 75 is considered pathological while a T score between 65 and 74 is considered borderline.

Full Information

First Posted
October 23, 2020
Last Updated
September 27, 2023
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
Ministero della Salute, Italy, Istituto Nazionale di Genetica Molecolare, Milan Italy, IRCCS Humanitas Milan Italy
search

1. Study Identification

Unique Protocol Identification Number
NCT04617587
Brief Title
Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood
Official Title
Structural Variations of the Neural Genome as Prognostic Biomarkers for Prematurity Related Neurodevelopmental Disorders in Childhood
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 3, 2020 (Actual)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
Ministero della Salute, Italy, Istituto Nazionale di Genetica Molecolare, Milan Italy, IRCCS Humanitas Milan Italy

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Preterms are early exposed to a stressful environment (i.e. excessive sensory stimulation and paucity of parental contact) with subsequent detrimental effects on brain maturation and neurodevelopmental outcomes. In contrast, early interventions seem to reduce stress exposure and promote neurodevelopment. The brain functional plasticity in response to environmental experiences can be partly attributed to changes in DNA methylation. In this context, LINE-1 (L1) promoter (18% of human genome) methylation/demethylation has been associated with L1 somatic mobilization in the brain genomes, contributing to experience-driven brain plasticity; this mechanism being deregulated in important neurological disease. This study aims at identifying and characterizing the role of L1 DNA repeats as a novel biomarker to predict long-term neurodevelopmental outcome in preterm infants. In addition, the study's secondary goal will be to define a preventive approach, based on early intervention strategies, for improving long-term neurodevelopmental outcomes.
Detailed Description
Around 25-50% of very preterm infants suffer from neurodevelopmental delays (motor, cognitive and behavioral problems), which are most likely related to brain micro-structural defects and impaired neuronal maturation and connectivity. These alterations in brain maturation occurring during the neonatal period may be implicated in long-term neurobehavioral disorders later experienced by preterm babies. There is increasing evidence that also stressful events (excessive sensory stimulation, paucity of parental contact and painful procedures) experienced in the Neonatal Intensive Care Unit (NICU) by preterm neonates can affect neurodevelopment through epigenetic mechanisms. The brain is a genomic mosaic, owing to somatic mutations that arise throughout development. It is already established that mobile genetic elements, including LINE-1 (L1), are one source of somatic mosaicism, inducing copy number variations in neural genome. Environmental experiences can drive brain plasticity at a molecular level, with changes in DNA methylation. In particular, L1 promoter methylation/demethylation is already associated with L1 mobilization in the brain genomes and its deregulation is linked with important neurological diseases. A preliminary study has shown the correlation between L1 promoter methylation levels and preterm birth. In addition, maternal care during early life has been reported to drive variability in L1 mobilization and methylation of the neural hippocampal genome in mice models. Several studies have reported how individualized developmental care in the NICU can ameliorate preterm infants' medical outcome and subsequent neurodevelopment. More recently, early intervention (EI) strategies based on parental training and multisensory stimulation, such as infant massage and visual stimulation, have been demonstrated to enhance child's neurodevelopment. These programs have the greatest potential to reduce environmental stress in preterms, promoting brain plasticity, optimizing dyadic interaction and ameliorating neurodevelopmental outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Birth
Keywords
Premature Birth, DNA Methylation, L1 Elements, Epigenometics, Early Intervention, Brain Development, Neurodevelopment, Parent-infant interaction, Massage therapy, Visual interaction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
104 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Early Intervention
Arm Type
Experimental
Arm Description
All the enrolled preterm infants are assigned to receive the early neurodevelopmental intervention during the NICU stay.
Intervention Type
Behavioral
Intervention Name(s)
Early Intervention
Intervention Description
The early intervention (EI) is delivered during the NICU stay. It is a multisensory intervention which consists in three parts: parental training, massage therapy and visual interaction. The EI is first focused on parental training, according to PremieStart Protocol, in order to train parents to: recognize signs of infant stress and alert-available behavior through the identification of infant's behavioral states; adopt principles of graded stimulation; sustain infant's attention and respond to infant's cues; optimize interactions and avoid overwhelming infants through facilitation strategies. The program is held in eight main sessions and one additional post-discharge session. In addition, parents are trained and invited to daily promote preterm baby massage therapy and visual interaction (visual fixation/tracking and visual attention).
Primary Outcome Measure Information:
Title
L1 Promoter Methylation Levels on Biological Materials
Description
Epigenetic analysis is performed on biological materials: cord blood sample and buccal swab at birth, peripheral blood sample and buccal swab at NICU discharge/term equivalent age, buccal swab collected during the follow up assessment at 12 and 24 months of corrected age.
Time Frame
Up to 24 months corrected age
Secondary Outcome Measure Information:
Title
Conventional and advanced brain Magnetic Resonance Imaging (MRI)
Description
Evaluation of brain development and maturation
Time Frame
Term equivalent age, approximately 40 weeks postmenstrual age
Title
Neurological Examination
Description
Hammersmith Neonatal Neurological Examination (HNNE)
Time Frame
Term equivalent age, approximately 40 weeks postmenstrual age
Title
General Movements Examination
Description
Prechtl's Qualitative Assessment of General Movements
Time Frame
Term equivalent age, approximately 40 weeks postmenstrual age
Title
Visual Assessment
Description
Neonatal Visual Assessment Battery developed by Ricci et al. The assessment evaluates the following items: ocular spontaneous motility, ability to fix and follow a target, reaction to colour, visual acuity and visual attention at distance.
Time Frame
Term equivalent age, approximately 40 weeks postmenstrual age
Title
Neurodevelopmental Outcome
Description
Children development assessed using the Griffiths Mental Development Scales, performed at 12 and 24 months of corrected age. Mean score is 100. General score has a Standard deviation of 12 and sub scales have a Standard Deviation of 16. Higher scores indicate better outcomes.
Time Frame
Up to 24 months corrected age
Title
Behavioral Outcome
Description
Children behavior assessed using the Child Behavior Checklist (CBCL). It is a parent report form to screen for emotional, behavioral and social problems. Lower scores indicate better outcomes. A T score above 75 is considered pathological while a T score between 65 and 74 is considered borderline.
Time Frame
24 months corrected age

10. Eligibility

Sex
All
Minimum Age & Unit of Time
24 Weeks
Maximum Age & Unit of Time
32 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Gestational age at birth between 24+0 and 32+6 weeks Mothers age over 18 years Good comprehension of the Italian language Written informed consent signed by both parents Exclusion Criteria: Infants with major genetic disorders and malformations Parents declined study participation Single-parent family Parents with obvious cognitive or psychiatric disorders and drug addiction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Monica Fumagalli, MD, PhD
Organizational Affiliation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Beatrice Bodega, PhD
Organizational Affiliation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Official's Role
Principal Investigator
Facility Information:
Facility Name
NICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
City
Milan
ZIP/Postal Code
20122
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
The dataset generated for this study will be made available on request in an anonymized version or in a grouped form in order to prevent patient identification.
Citations:
PubMed Identifier
32582595
Citation
Fontana C, De Carli A, Ricci D, Dessimone F, Passera S, Pesenti N, Bonzini M, Bassi L, Squarcina L, Cinnante C, Mosca F, Fumagalli M. Effects of Early Intervention on Visual Function in Preterm Infants: A Randomized Controlled Trial. Front Pediatr. 2020 Jun 4;8:291. doi: 10.3389/fped.2020.00291. eCollection 2020.
Results Reference
background
PubMed Identifier
19026450
Citation
Newnham CA, Milgrom J, Skouteris H. Effectiveness of a modified Mother-Infant Transaction Program on outcomes for preterm infants from 3 to 24 months of age. Infant Behav Dev. 2009 Jan;32(1):17-26. doi: 10.1016/j.infbeh.2008.09.004. Epub 2008 Nov 20.
Results Reference
background
PubMed Identifier
29567711
Citation
Bedrosian TA, Quayle C, Novaresi N, Gage FH. Early life experience drives structural variation of neural genomes in mice. Science. 2018 Mar 23;359(6382):1395-1399. doi: 10.1126/science.aah3378.
Results Reference
background
PubMed Identifier
17996405
Citation
Ricci D, Romeo DM, Serrao F, Cesarini L, Gallini F, Cota F, Leone D, Zuppa AA, Romagnoli C, Cowan F, Mercuri E. Application of a neonatal assessment of visual function in a population of low risk full-term newborn. Early Hum Dev. 2008 Apr;84(4):277-80. doi: 10.1016/j.earlhumdev.2007.10.002. Epub 2007 Nov 8.
Results Reference
background
PubMed Identifier
19420271
Citation
Guzzetta A, Baldini S, Bancale A, Baroncelli L, Ciucci F, Ghirri P, Putignano E, Sale A, Viegi A, Berardi N, Boldrini A, Cioni G, Maffei L. Massage accelerates brain development and the maturation of visual function. J Neurosci. 2009 May 6;29(18):6042-51. doi: 10.1523/JNEUROSCI.5548-08.2009.
Results Reference
background

Learn more about this trial

Novel Epigenetic Biomarker for Prematurity Related Neurodevelopmental Disorders in Childhood

We'll reach out to this number within 24 hrs